Amarin Corporation PLC (AMRN) Informed by FDA of October 16th Advisory Committee Date in Connection With Supplemental New Drug Application (sNDA) for Vascepa® in the Treatment of Patients With High Triglycerides (>200 mg/dL and <500 mg/dL) With Mixed Dyslipidemia
6/19/2013
More...
|
Janssen Research & Development Release: Latest Data for Type 2 Diabetes Treatment INVOKANA™ (canagliflozin) to be Presented at American Diabetes Association Annual Meeting
6/19/2013
More...
|
ALK-Abello A/S Announces Positive Outcome of Pivotal Phase III Trial With New Allergy Immunotherapy Tablet Against House Dust Mite Allergy
6/19/2013
More...
|
Newron Pharmaceuticals (NWRN) Release: Safinamide Phase III Study Results Presented at 2013 MDS Meeting
6/19/2013
More...
|
PRANA Biotechnology (PRAN) Presents New Benchmark Test to Assess Huntington's Disease Patients in Clinical Trials
6/19/2013
More...
|
Pluristem Therapeutics (PSTI) Provides Update on Clinical Status of IC Trials
6/19/2013
More...
|
ChemoCentryx, Inc. (CCXI) Announces Completion of Target Enrollment of CCX140 Phase II Clinical Trial in Diabetic Nephropathy
6/19/2013
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY) and Seattle Genetics, Inc. (SGEN) Highlight Post-Hoc Analysis Examining Progression-free Survival With ADCETRIS® (brentuximab vedotin) Versus Prior Therapy at the International Conference on Malignant Lymphoma
6/19/2013
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Reports Successful Completion of FDA Requested Immunocompetency Studies on Oxycyte®
6/19/2013
More...
|
Nektar Therapeutics (CA) (NKTR) Presents Positive Data From Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
6/19/2013
More...
|
Allied's Herpes Vaccine Progresses to Phase 1 Clinical Trial
6/19/2013
More...
|
Vaxart, Inc.’s Groundbreaking Tablet Influenza Vaccine Generates Protective Antibody Levels in Humans
6/19/2013
More...
|
Senesco Technologies, Inc. (SNT) Announces Results of Cohort 2 of its SNS01-T Phase 1b/2a Trial
6/19/2013
More...
|
Amarantus BioSciences, Inc. Reports Positive Results on MANF Neuroprotective Properties Demonstrated in Preclinical Study in China
6/19/2013
More...
|
DiaTech Oncology Test Shows Positive Results, Identifies New Therapeutic Strategies for Patients With Lung Cancer and Ovarian Cancer
6/19/2013
More...
|
Juvenile Diabetes Research Foundation Release: New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development
6/19/2013
More...
|
CryoLife, Inc. (CRY) Receives Conditional IDE Approval to Begin Clinical Trials for PerClot® in the U.S.
6/19/2013
More...
|
Curie-Cancer and Sanofi (France) (SAN.PA) Cooperate in Research on Ovarian Cancer
6/19/2013
More...
|
Athera Biotechnologies and Boehringer Ingelheim Corporation Enter Into an Option Agreement on a Novel Therapy for Atherosclerosis
6/19/2013
More...
|
Covance Inc. (CVD) Hosts Governor Pence, PhRMA and Eli Lilly and Company (LLY) to Highlight Economic and Health Impact of Clinical Trial Research in Indiana
6/19/2013
More...
|
Blirt SA to Work With lsbc on Out-Licensing Its Antifungal Assets
6/19/2013
More...
|
Lophius Biosciences GmbH Joins NEU² and Receives Substantial Grant Funding for the Diagnosis and Monitoring of Multiple Sclerosis
6/19/2013
More...
|
VGTI Florida Scientists to Receive $3.6 Million in National Institutes of Health (NIH) Research Grants
6/19/2013
More...
|
Raptor Pharmaceutical Inc. (RPTP)'s PROCYSBI™ Now Commercially Available in the U.S. for Nephropathic Cystinosis Patients
6/19/2013
More...
|
Aurora Algae Expands Patent Portfolio, Accelerates Biotech Innovation
6/19/2013
More...
|
BioInvent (BOVNF) Implements a Rights Issue of Approx. SEK 22 Million
6/19/2013
More...
|
Biodel Inc. (BIOD) Prices Public Offering of Common Stock
6/19/2013
More...
|
Biodel Inc. (BIOD) Announces Proposed Public Offering of Common Stock
6/19/2013
More...
|
Mylan Specialty Joins Forces With Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign
6/19/2013
More...
|
Immunotech Laboratories Announces the Results From Gap Analysis Report
6/19/2013
More...
|
ConvaTec Launches Enhanced Starter Kit™ Web Ordering Tool
6/19/2013
More...
|
VIVUS, Inc. (VVUS) Posts Investor Presentation
6/19/2013
More...
|
Intellect Neurosciences, Inc. Engages Evli Corporate Finance to Explore Strategic Alternatives to Maximize Shareholder Value
6/19/2013
More...
|
Mylan Inc. (MYL) Announces Pricing of Senior Notes
6/19/2013
More...
|
Actavis (ACT) Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition
6/19/2013
More...
|
Fibrocell Science, Inc. to Join Russell Indexes
6/19/2013
More...
|
IMS Health (RX) Study Identifies $200+ Billion Annual Opportunity From Using Medicines More Responsibly
6/19/2013
More...
|
Bayer HealthCare (BAY) Animal Health Marks Its 50th Anniversary in Shawnee, Kansas
6/19/2013
More...
|
Valeant Pharmaceuticals International (VRX) Prices Public Offering Of Common Shares
6/19/2013
More...
|
Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock
6/19/2013
More...
|
Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation
6/19/2013
More...
|
GSMA: mHealth Grand Tour to Feature a First-of-Its-Kind Live Diabetes Research Study
6/19/2013
More...
|
Mo Bio Laboratories, Inc. Launches the First Kit for Protein Extraction From Soil
6/19/2013
More...
|
Resolutions at BioInvent (BOVNF)'s Extraordinary General Meeting
6/19/2013
More...
|
RXi Pharmaceuticals (RXII) Begins Trading on OTCQX®
6/19/2013
More...
|
H. Lundbeck A/S (LUN.CO) Intends to Appeal the Decision From the European Commission
6/19/2013
More...
|
Actavis (ACT) and Kissei Pharmaceutical Co., Ltd. File Lawsuits Against Sandoz, Inc. and Hetero for Infringement of Rapaflo® Patent
6/19/2013
More...
|
SCM Pharma Limited Release: Medicines and Healthcare Products Regulatory Agency Approval for CDMO's Commercial Facility
6/19/2013
More...
|
TKL Research, Inc. is Building New Clinical Research Facility in Fair Lawn, N.J.
6/19/2013
More...
|
Impact Analytical Opens New State-of-the-Art Laboratory Facility
6/19/2013
More...
|
Agilent Technologies, Inc. (Santa Clara, California) (A) Announces Offering of Senior Notes
6/19/2013
More...
|
China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013
6/19/2013
More...
|
Eli Lilly and Company (LLY) Declares Third-Quarter 2013 Dividend
6/19/2013
More...
|
Elite Pharmaceuticals, Inc. (ELI) Announces 2013 Fiscal Year End Conference Call on Monday, June 24, 2013
6/19/2013
More...
|
Promedior Adds Howard J. Weisman to Board of Directors
6/19/2013
More...
|
PSI Names Andrea Cracraft Director Clinical Operations North America
6/19/2013
More...
|
Novozymes A/S (NZYMb.CO) Release: Science as Art: 3D Mural Depicts Future of Agriculture
6/19/2013
More...
|
RIFM Adopts Bluescreen HC™ for Early Genetic Toxicology Screening of Fragrance Materials
6/19/2013
More...
|
A Prized Experience: Santa Clara University Reveals
6/19/2013
More...
|
Ariad Pharmaceuticals, Inc. (ARIA) Honored With Gold Stevie® Awards as Pharmaceutical Company of the Year at 2013 American Business Awards
6/19/2013
More...
|
Isis Pharmaceuticals, Inc. (ISIS) to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House
6/19/2013
More...
|
Cellectis SA Combined General Shareholders’ Meeting of June 14, 2013
6/19/2013
More...
|
Synthetic Biologics, Inc. (SYN) to Present at OneMedForum New York 2013
6/19/2013
More...
|
Vectura Group plc (VEC.L) to Present at J.P. Morgan European Healthcare Conference
6/19/2013
More...
|
Nuvo Research Inc. (NRI.TO) Announces Director Election Results of its Annual General Meeting
6/19/2013
More...
|
Nordic Life Science Days 2013: Register for Your Free Media Pass
6/19/2013
More...
|
University of California, Los Angeles (UCLA) Presents Data on MediciNova, Inc.'s MN-166 in Methamphetamine Addiction at the 75th Annual Meeting of the College on Problems of Drug Dependence
6/19/2013
More...
|
The 12th World Congress of the OESO Will Take Place at UNESCO Headquarters in Paris From 27 to 30 August
6/19/2013
More...
|
NeuroDerm Ltd. Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease
6/19/2013
More...
|
TG Therapeutics, Inc. (MHA) Announces Presentation of Pre-Clinical Data on the Combination of TG-1101 and TGR-1202 at the International Conference on Malignant Lymphoma, Lugano, Switzerland
6/19/2013
More...
|
DATATRAK International, Inc. (DATA) to Introduce uPRO™ Solution at 49th Annual Drug Information Association Meeting
6/19/2013
More...
|
LabConnect, LLC to Showcase Innovative Ambient Sample Shipping System at Drug Information Association
6/19/2013
More...
|
MedNet Solutions to Spotlight iMedNet EDC at the 49th Drug Information Association Annual Meeting
6/19/2013
More...
|